Hematopoietic stem cells improve dopaminergic neuron in the MPTP-mice

Jingwei Lu, Suman Kanji, Reeva Aggarwal, Manjusri Das, Matthew Joseph, Lai Chu Wu, Hai Quan Mao, Vincent J Pompili, Maria Hadjiconstantinou, Hiranmoy Das

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Because of their ability for self-renewal and neural differentiation, stem cells are believed to be ideal for cell replacement therapy in Parkinson's disease (PD). Nanofiber-expanded human umbilical cord hematopoietic stem cells (HUHSCs) are advantageous to other stem cells as they provide a source of unlimited stem cell production for clinical application. In this study, we investigated whether 1. nanofiber-expanded HUHSCs are capable of neural differentiation in vitro, and 2. they could improve dopaminergic neuron morphology in the caudate/putamen (CPu) and substantia nigra pars compacta (SNc) of the MPTP-mouse model of PD. When cultured under neural differentiation conditions, nanofiber-expanded HUHSCs were able to undergo neural differentiation in vitro, as determined by gene and protein expression of neural markers such as MAP2, NeuN, HuC, GFAP and Oligo2. Thirty days after a single intracardioventricular injection of HUHSCs to MPTP-mice there was a significant recovery of tyrosine hydroxylase (TH) immunostaining in CPu. There was an increase in the size and staining density of TH+ cells in SNc, while their number was unchanged.

Original languageEnglish (US)
Pages (from-to)970-981
Number of pages12
JournalFrontiers in Bioscience
Volume18
Issue number3
DOIs
StatePublished - Jun 1 2013

Fingerprint

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Umbilical Cord
Dopaminergic Neurons
Hematopoietic Stem Cells
Stem cells
Nanofibers
Neurons
Putamen
Tyrosine 3-Monooxygenase
Parkinson Disease
Stem Cells
Neural Stem Cells
Cell- and Tissue-Based Therapy
Staining and Labeling
Gene Expression
Injections
Proteins
Recovery
In Vitro Techniques
Pars Compacta

Keywords

  • Neuron
  • Parkinson's disease
  • Regeneration
  • Umbilical cord. stem cells

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Lu, J., Kanji, S., Aggarwal, R., Das, M., Joseph, M., Wu, L. C., ... Das, H. (2013). Hematopoietic stem cells improve dopaminergic neuron in the MPTP-mice. Frontiers in Bioscience, 18(3), 970-981. https://doi.org/10.2741/4156

Hematopoietic stem cells improve dopaminergic neuron in the MPTP-mice. / Lu, Jingwei; Kanji, Suman; Aggarwal, Reeva; Das, Manjusri; Joseph, Matthew; Wu, Lai Chu; Mao, Hai Quan; Pompili, Vincent J; Hadjiconstantinou, Maria; Das, Hiranmoy.

In: Frontiers in Bioscience, Vol. 18, No. 3, 01.06.2013, p. 970-981.

Research output: Contribution to journalArticle

Lu, J, Kanji, S, Aggarwal, R, Das, M, Joseph, M, Wu, LC, Mao, HQ, Pompili, VJ, Hadjiconstantinou, M & Das, H 2013, 'Hematopoietic stem cells improve dopaminergic neuron in the MPTP-mice', Frontiers in Bioscience, vol. 18, no. 3, pp. 970-981. https://doi.org/10.2741/4156
Lu J, Kanji S, Aggarwal R, Das M, Joseph M, Wu LC et al. Hematopoietic stem cells improve dopaminergic neuron in the MPTP-mice. Frontiers in Bioscience. 2013 Jun 1;18(3):970-981. https://doi.org/10.2741/4156
Lu, Jingwei ; Kanji, Suman ; Aggarwal, Reeva ; Das, Manjusri ; Joseph, Matthew ; Wu, Lai Chu ; Mao, Hai Quan ; Pompili, Vincent J ; Hadjiconstantinou, Maria ; Das, Hiranmoy. / Hematopoietic stem cells improve dopaminergic neuron in the MPTP-mice. In: Frontiers in Bioscience. 2013 ; Vol. 18, No. 3. pp. 970-981.
@article{80f32d4016754bff9a2f8d028c390562,
title = "Hematopoietic stem cells improve dopaminergic neuron in the MPTP-mice",
abstract = "Because of their ability for self-renewal and neural differentiation, stem cells are believed to be ideal for cell replacement therapy in Parkinson's disease (PD). Nanofiber-expanded human umbilical cord hematopoietic stem cells (HUHSCs) are advantageous to other stem cells as they provide a source of unlimited stem cell production for clinical application. In this study, we investigated whether 1. nanofiber-expanded HUHSCs are capable of neural differentiation in vitro, and 2. they could improve dopaminergic neuron morphology in the caudate/putamen (CPu) and substantia nigra pars compacta (SNc) of the MPTP-mouse model of PD. When cultured under neural differentiation conditions, nanofiber-expanded HUHSCs were able to undergo neural differentiation in vitro, as determined by gene and protein expression of neural markers such as MAP2, NeuN, HuC, GFAP and Oligo2. Thirty days after a single intracardioventricular injection of HUHSCs to MPTP-mice there was a significant recovery of tyrosine hydroxylase (TH) immunostaining in CPu. There was an increase in the size and staining density of TH+ cells in SNc, while their number was unchanged.",
keywords = "Neuron, Parkinson's disease, Regeneration, Umbilical cord. stem cells",
author = "Jingwei Lu and Suman Kanji and Reeva Aggarwal and Manjusri Das and Matthew Joseph and Wu, {Lai Chu} and Mao, {Hai Quan} and Pompili, {Vincent J} and Maria Hadjiconstantinou and Hiranmoy Das",
year = "2013",
month = "6",
day = "1",
doi = "10.2741/4156",
language = "English (US)",
volume = "18",
pages = "970--981",
journal = "Frontiers in Bioscience - Landmark",
issn = "1093-9946",
publisher = "Frontiers in Bioscience",
number = "3",

}

TY - JOUR

T1 - Hematopoietic stem cells improve dopaminergic neuron in the MPTP-mice

AU - Lu, Jingwei

AU - Kanji, Suman

AU - Aggarwal, Reeva

AU - Das, Manjusri

AU - Joseph, Matthew

AU - Wu, Lai Chu

AU - Mao, Hai Quan

AU - Pompili, Vincent J

AU - Hadjiconstantinou, Maria

AU - Das, Hiranmoy

PY - 2013/6/1

Y1 - 2013/6/1

N2 - Because of their ability for self-renewal and neural differentiation, stem cells are believed to be ideal for cell replacement therapy in Parkinson's disease (PD). Nanofiber-expanded human umbilical cord hematopoietic stem cells (HUHSCs) are advantageous to other stem cells as they provide a source of unlimited stem cell production for clinical application. In this study, we investigated whether 1. nanofiber-expanded HUHSCs are capable of neural differentiation in vitro, and 2. they could improve dopaminergic neuron morphology in the caudate/putamen (CPu) and substantia nigra pars compacta (SNc) of the MPTP-mouse model of PD. When cultured under neural differentiation conditions, nanofiber-expanded HUHSCs were able to undergo neural differentiation in vitro, as determined by gene and protein expression of neural markers such as MAP2, NeuN, HuC, GFAP and Oligo2. Thirty days after a single intracardioventricular injection of HUHSCs to MPTP-mice there was a significant recovery of tyrosine hydroxylase (TH) immunostaining in CPu. There was an increase in the size and staining density of TH+ cells in SNc, while their number was unchanged.

AB - Because of their ability for self-renewal and neural differentiation, stem cells are believed to be ideal for cell replacement therapy in Parkinson's disease (PD). Nanofiber-expanded human umbilical cord hematopoietic stem cells (HUHSCs) are advantageous to other stem cells as they provide a source of unlimited stem cell production for clinical application. In this study, we investigated whether 1. nanofiber-expanded HUHSCs are capable of neural differentiation in vitro, and 2. they could improve dopaminergic neuron morphology in the caudate/putamen (CPu) and substantia nigra pars compacta (SNc) of the MPTP-mouse model of PD. When cultured under neural differentiation conditions, nanofiber-expanded HUHSCs were able to undergo neural differentiation in vitro, as determined by gene and protein expression of neural markers such as MAP2, NeuN, HuC, GFAP and Oligo2. Thirty days after a single intracardioventricular injection of HUHSCs to MPTP-mice there was a significant recovery of tyrosine hydroxylase (TH) immunostaining in CPu. There was an increase in the size and staining density of TH+ cells in SNc, while their number was unchanged.

KW - Neuron

KW - Parkinson's disease

KW - Regeneration

KW - Umbilical cord. stem cells

UR - http://www.scopus.com/inward/record.url?scp=84880526930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880526930&partnerID=8YFLogxK

U2 - 10.2741/4156

DO - 10.2741/4156

M3 - Article

VL - 18

SP - 970

EP - 981

JO - Frontiers in Bioscience - Landmark

JF - Frontiers in Bioscience - Landmark

SN - 1093-9946

IS - 3

ER -